Corvus Pharmaceuticals Inc Stock (CRVS) Forecast
The Corvus Pharmaceuticals Inc (CRVS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.59, representing a -1.41% decrease from the current price of $9.73. The highest analyst price target is $10.12, and the lowest is $9.07.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRVS Price Target
Average 9.21 (-5.35% Downside)
Is Corvus Pharmaceuticals Inc (CRVS) A Buy Now?
Oscillators
Buy: 2 · Sell: 0 · Neutral: 5Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, CRVS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CRVS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.60 indicates that CRVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.35 indicates that CRVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.00 indicates that CRVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 20.51 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of -49.25 indicates that CRVS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CRVS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Corvus Pharmaceuticals Inc financial reports and earnings history, Corvus Pharmaceuticals Inc (CRVS) stock could reach $22.15 by 2030, $35.51 by 2040 and $45.29 by 2050. See the projected annual prices until 2050 of the Corvus Pharmaceuticals Inc stock below:
- Corvus Pharmaceuticals Inc (CRVS) is expected to reach an average price of $32.75 in 2035, with a high prediction of $34.30 and a low estimate of $23.04. This indicates an +236.59% change from the last recorded price of $9.73.
- Corvus Pharmaceuticals Inc (CRVS) stock is projected to chart a bullish course in 2040, with an average price target of $35.35, representing an +263.32% change from its current level. The forecast ranges from a conservative $30.39 to a sky-high $35.51.
- Our analysts predict Corvus Pharmaceuticals Inc (CRVS) to change +326.83% by 2045, soaring from $34.28 to an average price of $41.53, potentially reaching $41.79. While $34.28 is the low estimate, the potential upside is significant.
- Corvus Pharmaceuticals Inc (CRVS) stock is expected to climb by 2050, reaching an average of $45.25, a +365.10% change from its current level. However, a wide range of estimates exists, with high and low targets of $45.29 and $37.56, respectively, highlighting the market's uncertainty.
Corvus Pharmaceuticals Inc Stock (CRVS) Year by Year Forecast
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2026
The predicted value for Corvus Pharmaceuticals Inc (CRVS) in 2026 is set at an average of $13.68. Estimates vary from a peak of $26.95 to a trough of $6.39, indicating an +40.58% surge from the present price of $9.73.
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Corvus Pharmaceuticals Inc (CRVS) is $8.73, with a high forecast of $9.39 and a low forecast of $8.30. This indicates an -10.26% decrease from the last price of $9.73.
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2028
In 2028, Corvus Pharmaceuticals Inc (CRVS) is projected to reach an average price of $10.88, with a high projection of $13.58 and a low estimate of $9.03. This indicates an +11.84% rise from the last price of $9.73.
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2029
The 2029 price forecast for Corvus Pharmaceuticals Inc Stock (CRVS) is $12.93 on average, with a high prediction of $15.76 and a low estimate of $11.16. This represents an +32.93% increase from the previous price of $9.73.
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2030
Corvus Pharmaceuticals Inc Stock (CRVS) is expected to reach an average price of $17.80 in 2030, with a high forecast of $22.15 and a low forecast of $15.43. This signifies an +82.95% surge from the last price of $9.73.
